Short answer · Medically reviewed summary · Last updated: 2026-04-07
Friedreich Ataxia (FRDA) is a progressive neurodegenerative disorder primarily identified by its official name, though it is historically and clinically referred to by several synonyms including Friedreich's ataxia, spinal ataxia, and hereditary spinal ataxia. In clinical settings, the abbreviation "FRDA" is the standard shorthand used by medical professionals to distinguish this specific genetic condition from other forms of hereditary ataxias. What are the historical and alternative names for Friedreich Ataxia? The condition was first described by Nikolaus Friedreich in the 1860s, leading to the eponym Friedreich Ataxia.
Friedreich Ataxia (FRDA) is a progressive neurodegenerative disorder primarily identified by its official name, though it is historically and clinically referred to by several synonyms including Friedreich's ataxia, spinal ataxia, and hereditary spinal ataxia. In clinical settings, the abbreviation "FRDA" is the standard shorthand used by medical professionals to distinguish this specific genetic condition from other forms of hereditary ataxias.
The condition was first described by Nikolaus Friedreich in the 1860s, leading to the eponym Friedreich Ataxia. In older medical literature, you may encounter terms such as "Friedreich's disease," "hereditary spinal sclerosis," or "Friedreich's spinal ataxia." These names were assigned before the genetic basis of the disease—a trinucleotide repeat expansion in the FXN gene—was fully understood. While these terms are largely historical, they occasionally persist in legacy patient records or older textbooks.
The variety of names for Friedreich Ataxia stems from the evolution of medical classification. Historically, many neurological conditions were named after the clinician who first documented the symptoms or the specific anatomical region affected, such as "spinal ataxia." As medical science transitioned toward molecular diagnostics, the nomenclature shifted to reflect the underlying genetic cause. Today, international databases harmonize these terms to ensure patients and researchers are referencing the same condition regardless of their geographic location or the medical tradition they follow.
To standardize patient care and clinical research, major health organizations use specific codes and identifiers for Friedreich Ataxia. Understanding these codes can be helpful when reviewing medical records or searching for clinical trials:
In modern clinical practice, Friedreich Ataxia is the universally accepted term. While the possessive form "Friedreich's ataxia" is still widely used in general conversation and by some organizations, the medical community increasingly prefers "Friedreich Ataxia" to align with current naming conventions for genetic disorders. The acronym FRDA is the standard designation used in clinical trial registries and research publications to maintain precision and brevity.
At DiseaseMaps.org, we have connected with 105 individuals living with Friedreich Ataxia. Through our community data, we observe that patients often encounter confusion when their medical records use different synonyms; however, consistent use of the term Friedreich Ataxia helps ensure clearer communication with neurology teams and specialists worldwide.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.